Paliperidone
Rykindo is a brand-name atypical antipsychotic medication containing risperidone, delivered as an extended-release injectable suspension. It is designed for maintenance treatment of schizophrenia and bipolar I disorder in adults, helping to reduce symptoms such as hallucinations, delusions, and mood instability. This long-acting formulation is administered every two weeks by healthcare professionals.
Rykindo is a long-acting injectable antipsychotic used to maintain control of schizophrenia and bipolar I disorder symptoms in adults.
Key facts at a glance
- RxNorm
- 2639728
- Generic
- Rykindo
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Rykindo is indicated for the maintenance treatment of schizophrenia in adults and for the maintenance treatment of bipolar I disorder in adults. It is not intended for acute treatment of these conditions but rather for ongoing symptom management in patients who have responded to risperidone therapy.
As an atypical antipsychotic, risperidone works by blocking dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. This dual antagonism helps reduce positive symptoms of schizophrenia and stabilizes mood in bipolar disorder. The extended-release formulation slowly delivers the medication over two weeks, maintaining steady drug levels.
Rykindo is administered as an intramuscular injection every two weeks by a healthcare professional. Common side effects include weight gain, sedation, and movement disorders. Patients should be monitored for metabolic changes, cardiovascular effects, and neuroleptic malignant syndrome. The medication should not be stopped abruptly, and dosage adjustments require medical supervision. Safety in pregnancy and pediatric patients has not been fully established.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy